Stimulating the sir2–spargel axis rescues exercise capacity and mitochondrial respiration in a Drosophila model of Barth syndrome

Stimulating the sir2–spargel axis rescues exercise capacity and mitochondrial respiration in a Drosophila model of Barth syndrome

Bibliographic Details
Main Authors:	Deena Damschroder, Rubén Zapata-Pérez, Kristin Richardson, Frédéric M. Vaz, Riekelt H. Houtkooper, Robert Wessells
Format:	Article
Language:	English
Published:	The Company of Biologists 2022-10-01
Series:	Disease Models & Mechanisms
Subjects:	nicotinamide riboside nad+ barth syndrome exercise tolerance drosophila tafazzin
Online Access:	http://dmm.biologists.org/content/15/10/dmm049279

Similar Items

Correction: Stimulating the sir2–spargel axis rescues exercise capacity and mitochondrial respiration in a Drosophila model of Barth syndrome
by: Deena Damschroder, et al.
Published: (2024-09-01)

Structural and Functional Characterization of NadR from <i>Lactococcus lactis</i>
by: Artem Stetsenko, et al.
Published: (2020-04-01)

Nicotinamide riboside kinase 1 protects against diet and age-induced pancreatic β-cell failure
by: Angelique Cercillieux, et al.
Published: (2022-12-01)

Loss of NAMPT and SIRT2 but not SIRT1 attenuate GLO1 expression and activity in human skeletal muscle
by: Edwin R. Miranda, et al.
Published: (2024-09-01)

NAD+ enhancers as therapeutic agents in the cardiorenal axis
by: Mariano Marín-Blázquez, et al.
Published: (2024-11-01)

Metabolic switch from fatty acid oxidation to glycolysis in knock‐in mouse model of Barth syndrome
by: Arpita Chowdhury, et al.
Published: (2023-08-01)

Nicotinamide Riboside and Phycocyanin Oligopeptides Affect Stress Susceptibility in Chronic Corticosterone-Exposed Rats
by: Cemal Orhan, et al.
Published: (2023-10-01)

Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells
by: Rachel S. Fletcher, et al.
Published: (2017-08-01)

Barth syndrome: mechanisms and management
by: Finsterer J
Published: (2019-06-01)

The Role of NAD<sup>+</sup> and NAD<sup>+</sup>-Boosting Therapies in Inflammatory Response by IL-13
by: Anton D. Pugel, et al.
Published: (2024-02-01)

Case Report: A Chinese child with Barth syndrome caused by a novel TAFAZZIN mutation
by: Mingxuan Che, et al.
Published: (2024-09-01)

Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
by: Nahid A Khan, et al.
Published: (2014-04-01)

NAD<sup>+</sup> Precursors: A Questionable Redundancy
by: Carles Canto
Published: (2022-07-01)

Rev1 deficiency induces a metabolic shift in MEFs that can be manipulated by the NAD+ precursor nicotinamide riboside
by: Sharath Anugula, et al.
Published: (2023-06-01)

NAD<sup>+</sup> Acts as a Protective Factor in Cellular Stress Response to DNA Alkylating Agents
by: Joanna Ruszkiewicz, et al.
Published: (2023-10-01)

Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR)
by: Juan Carlos Rivera, et al.
Published: (2024-05-01)

Remission of social behavior impairment by oral administration of a precursor of NAD in CD157, but not in CD38, knockout mice
by: Maria Gerasimenko, et al.
Published: (2023-05-01)

A novel intronic splice site tafazzin gene mutation detected prenatally in a family with Barth syndrome
by: Bakšienė M, et al.
Published: (2016-12-01)

Nicotinamide Riboside Regulates Chemotaxis to Decrease Inflammation and Ameliorate Functional Recovery Following Spinal Cord Injury in Mice
by: Yan Li, et al.
Published: (2024-02-01)

The Role of NAD<sup>+</sup> in Metabolic Regulation of Adipose Tissue: Implications for Obesity-Induced Insulin Resistance
by: Tatjana Ruskovska, et al.
Published: (2023-09-01)

Re-Expression of Tafazzin Isoforms in TAZ-Deficient C6 Glioma Cells Restores Cardiolipin Composition but Not Proliferation Rate and Alterations in Gene Expression
by: Gayatri Jagirdar, et al.
Published: (2022-07-01)

Corrigendum: Re-expression of tafazzin isoforms in TAZ-deficient C6 glioma cells restores cardiolipin composition but not proliferation rate and alterations in gene expression
by: Gayatri Jagirdar, et al.
Published: (2022-08-01)

Epithelial NAD+ depletion drives mitochondrial dysfunction and contributes to intestinal inflammation
by: Elizabeth A. Novak, et al.
Published: (2023-09-01)

Metabolic rescue ameliorates mitochondrial encephalo‐cardiomyopathy in murine and human iPSC models of Leigh syndrome
by: Jin‐Young Yoon, et al.
Published: (2022-07-01)

Nicotinamide riboside kinases regulate skeletal muscle fiber-type specification and are rate-limiting for metabolic adaptations during regeneration
by: Tanja Sonntag, et al.
Published: (2022-11-01)

Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy
by: Malte Hachmann, et al.
Published: (2024-04-01)

Phenotypic Characterization of Female Carrier Mice Heterozygous for Tafazzin Deletion
by: Michelle V. Tomczewski, et al.
Published: (2023-09-01)

Phenotypic Characterization of Male <i>Tafazzin</i>-Knockout Mice at 3, 6, and 12 Months of Age
by: Michelle V. Tomczewski, et al.
Published: (2023-02-01)

How to mitigate neurological and cardiac decompensation in Leigh syndrome: Can nicotinamide riboside be an answer?
by: Alessandro Prigione, et al.
Published: (2022-09-01)

Nicotinamide Riboside Augments Human Macrophage Migration via SIRT3-Mediated Prostaglandin E2 Signaling
by: Jing Wu, et al.
Published: (2024-03-01)

Nicotinamide mononucleotide supplementation rescues mitochondrial and energy metabolism functions and ameliorates inflammatory states in the ovaries of aging mice
by: Jinghui Liang, et al.
Published: (2024-10-01)

Comparison of protective effects of nicotinamide mononucleotide and nicotinamide riboside on DNA damage induced by cisplatin in HeLa cells
by: Shuting Qiu, et al.
Published: (2024-03-01)

Diminished exercise capacity and mitochondrial bc1 complex deficiency in tafazzin-knockdown mice.
by: Corey ePowers, et al.
Published: (2013-04-01)

Nicotinamide-riboside shifts the differentiation of human primary white adipocytes to beige adipocytes impacting substrate preference and uncoupling respiration through SIRT1 activation and mitochondria-derived reactive species production
by: Lilla Nagy, et al.
Published: (2022-08-01)

Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model
by: Zhenye Zhu, et al.
Published: (2025-01-01)

Axonal Protection by Oral Nicotinamide Riboside Treatment with Upregulated AMPK Phosphorylation in a Rat Glaucomatous Degeneration Model
by: Ibuki Arizono, et al.
Published: (2023-08-01)

Supplementation with NAD+ and its precursors: A rescue of female reproductive diseases
by: Lan Li, et al.
Published: (2024-07-01)

The effects of genetic background on exercise performance in Drosophila
by: Deena Damschroder, et al.
Published: (2020-10-01)

Function of NAD metabolism in white adipose tissue: lessons from mouse models
by: So Young Kwon, et al.
Published: (2024-12-01)

Editorial Roland Barthes Plural
by: Carolina Bellocchio, et al.
Published: (2015-12-01)